Comparing the Effects of Manual Cross Friction Massage Versus Instrument-Assisted Soft Tissue Mob… (NCT07695064) | Clinical Trial Compass
CompletedNot Applicable
Comparing the Effects of Manual Cross Friction Massage Versus Instrument-Assisted Soft Tissue Mobilization on Pain, Range of Motion, And Functional Disability in Patients With Chronic Lateral Epicondylitis: A Randomized Controlled Trial
Pakistan36 participantsStarted 2026-01-11
Plain-language summary
This was a randomized controlled trial done to to compare the effect of manual Cross Friction Massage and IASTM in reducing pain , range of motion and functional disability in patients with chronic lateral epicondylitis
Who can participate
Age range
18 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Both male and female aged between 18 to 60 years with a clinical diagnosis of lateral elbow pain lasting for≥ 6 months duration VAS score ≥ 4 during resisted wrist extension or grip activity ≥1 of the following tests being positive . Mill's test pain on passive wrist flexion and elbow extension Cozen's test pain on resisted wrist extension, elbow extended, wrist in flexion and medial deviation .
Painful palpation at the origin of the ECRB or lateral epicondyle
Exclusion Criteria:
* Participants will be excluded as:
History of recent fracture,dislocation,or surgery near the elbow joint in the last 3 month Neurological or systemic inflammatory conditions (e.g., rheumatoid arthritis) Current use of corticosteroid injections in the elbow region within the past 6 weeks Previous physiotherapy interventions for the same complaint in the last 3 months.
Skin disorders or open wounds near the treatment area.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Visual Analog Scale.
Timeframe: Assessments were performed at baseline (week 0) and post intervention (week 6).
2
Goniometer
Timeframe: Assessments was performed at baseline (week 0) and post intervention (week 6).